Newly approved cancer drug targets aggressive form of “deadly disease.”

A new drug regimen for certain types of Pancreatic cancer recently received approval from the US Food and Drug Administration (FDA) – the first new drug in almost a decade.

Onivyde (irinotecan liposome), an injectable drug from Ipsen, has been approved for use along with oxaliplatin, fluorouracil and leucovorin as therapy for patients with metastatic pancreatic adenocarcinoma (mPDAC).

According to the National Institutes of Health (NIH), this type of cancer is an aggressive malignancy with an average life expectancy of between eight and eleven months.


The approval was based on a randomized controlled trial According to an FDA press release, this included 770 patients with metastatic pancreatic adenocarcinoma who had not previously received chemotherapy.

The group of patients who received the new regimen via an IV infusion showed “significant improvements” in survival and response rates compared to the control group.

A new drug regimen for certain types of pancreatic cancer was recently approved by the U.S. Food and Drug Administration. (iStock)

The medication is administered intravenously in 90-minute sessions every two weeks.

“I hope that this therapy represents a new reference – that is, we will complement it in the future,” said Dr. Zev Wainberg, professor of medicine and co-director of the UCLA GI Oncology Program in Los Angeles, told Fox News Digital.

AI has been proven to predict the risk of pancreatic cancer long before symptoms appear

“We needed clarity on the data provided by the Phase 3 trial before proceeding.”

Metastatic pancreatic cancer Wainberg noted that it is one of the most difficult cancers to treat because it does not respond as well to new drugs that work on other types of the disease.

“Unfortunately, patients are often very sick and many cancers spread too quickly for a drug to work like it does for other cancers,” he noted.

Metastatic pancreatic cancer is…

Read Complete News ➤

Benefits of eating guava for Americans